genedrive plc (LON:GDR – Get Free Report) shot up 14.3% during trading on Thursday . The stock traded as high as GBX 1.20 and last traded at GBX 1.20. Approximately 2,583,513 shares traded hands during trading, a decline of 58% from the average daily volume of 6,164,894 shares. The stock had previously closed at GBX 1.05.
genedrive Price Performance
The firm has a market capitalization of £19.27 million, a price-to-earnings ratio of -1.52 and a beta of 1.02. The stock’s fifty day moving average price is GBX 1.21 and its two-hundred day moving average price is GBX 1.08. The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Featured Articles
- Five stocks we like better than genedrive
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
